In December 2025, the city of Samcheok, Republic of Korea, sent an overseas delegation to explore practical ways to advance the Advanced Accelerator-Based Medical Industry Cluster Project, which aims to establish a medical and industrial ecosystem centered on a heavy-ion accelerator.
As part of the visit, the delegation toured the NHa (Normandy Hadron Therapy) Center in Caen, France, where the C400 IONS heavy-ion accelerator cancer treatment facility is currently being developed. The visit provided an opportunity to review examples of collaboration in education and research, as well as regional industry partnerships, and to discuss strategies for building a sustainable ecosystem in which medical care, industry, and education can grow together.
The delegation also visited the headquarters of IBA (Ion Beam Applications) in Belgium, a global leader in medical particle accelerator technology. During the meeting, they reviewed key aspects of heavy-ion accelerator deployment, including project timelines, the expected time required to begin operations, and frameworks for technology transfer and maintenance. These discussions also helped outline potential areas of cooperation with the Samcheok Dogye medical project.
IBA is internationally recognized for its competitiveness in particle therapy equipment. With extensive technological expertise and experience in global projects, the company has played a leading role in advancing particle therapy and delivering innovative cancer treatment solutions to medical institutions worldwide.
Through continued collaboration with IBA, Energyflow aim to support the advancement of Korea’s accelerator-based medical technologies. We also hope that more Korean institutions will engage in exchanges with IBA, helping to foster a dynamic medical and industrial ecosystem where technology, industry, research, and education are closely interconnected.